Gene-Tailored therapy shows promise for lung cancer patients
Disease control
Completed
This study tested whether customizing chemotherapy based on two genetic markers (EGFR mutations and BRCA1 levels) improves outcomes for people with advanced lung adenocarcinoma. 153 patients received treatments matched to their tumor's genetic profile. The goal was to see if this…
Phase: NA • Sponsor: Spanish Lung Cancer Group • Aim: Disease control
Last updated May 17, 2026 05:06 UTC